360 related articles for article (PubMed ID: 28634229)
1. Akt activation by Ca
Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
[TBL] [Abstract][Full Text] [Related]
2. CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis.
Chen Z; Sun X; Xia Z; Wang J; Guo N; Zhang Y
Comput Math Methods Med; 2022; 2022():7187940. PubMed ID: 35309839
[TBL] [Abstract][Full Text] [Related]
3. Calcium/calmodulin-dependent protein kinase kinase 2 mediates pleiotropic effects of epidermal growth factor in cancer cells.
Dai S; Venturini E; Yadav S; Lin X; Clapp D; Steckiewicz M; Gocher-Demske AM; Hardie DG; Edelman AM
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119252. PubMed ID: 35271909
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract][Full Text] [Related]
5. SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells.
Kodigepalli KM; Dutta PS; Bauckman KA; Nanjundan M
FEBS Lett; 2013 Jan; 587(1):5-16. PubMed ID: 23178716
[TBL] [Abstract][Full Text] [Related]
6. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
[TBL] [Abstract][Full Text] [Related]
8. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of an R311C variant of Ca
Xy Ling N; Langendorf CG; Hoque A; Galic S; Loh K; Kemp BE; Gundlach AL; Oakhill JS; Scott JW
Bipolar Disord; 2020 Dec; 22(8):841-848. PubMed ID: 32216002
[TBL] [Abstract][Full Text] [Related]
10. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.
Chen BC; Wu WT; Ho FM; Lin WW
J Biol Chem; 2002 Jul; 277(27):24169-79. PubMed ID: 11976320
[TBL] [Abstract][Full Text] [Related]
12. CaM kinase control of AKT and LNCaP cell survival.
Schmitt JM; Smith S; Hart B; Fletcher L
J Cell Biochem; 2012 May; 113(5):1514-26. PubMed ID: 22173970
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
14. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
[TBL] [Abstract][Full Text] [Related]
15. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.
Tang HJ; Jin X; Wang S; Yang D; Cao Y; Chen J; Gossett DR; Lin J
Gynecol Oncol; 2006 Feb; 100(2):308-17. PubMed ID: 16209885
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase-mediated feedback phosphorylation controls the Ca
Nakanishi A; Hatano N; Fujiwara Y; Sha'ri A; Takabatake S; Akano H; Kanayama N; Magari M; Nozaki N; Tokumitsu H
J Biol Chem; 2017 Dec; 292(48):19804-19813. PubMed ID: 28974582
[TBL] [Abstract][Full Text] [Related]
17. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
Najafov A; Shpiro N; Alessi DR
Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
[TBL] [Abstract][Full Text] [Related]
18. 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner.
Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L
Neoplasia; 2012 Aug; 14(8):719-31. PubMed ID: 22952425
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
20. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
